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Munich, GermanyABSTRACT Intramembrane proteolysis has emerged as a key mechanism required for membrane proteostasis and cellular
signaling. One of the intramembrane-cleaving proteases (I-CLiPs), g-secretase, is also intimately implicated in Alzheimer’s
disease, a major neurodegenerative disease and leading cause of dementia. High-resolution crystal structural analyses have
revealed that I-CLiPs harbor their active sites buried deeply in the membrane bilayer. Surprisingly, however, the key kinetic
constants of these proteases, turnover number kcat and catalytic efficiency kcat/KM, are largely unknown. By investigating the
kinetics of intramembrane cleavage of the Alzheimer’s disease-associated b-amyloid precursor protein in vitro and in human
embryonic kidney cells, we show that g-secretase is a very slow protease with a kcat value similar to those determined recently
for rhomboid-type I-CLiPs. Our results indicate that low turnover numbers may be a general feature of I-CLiPs.INTRODUCTIONIntramembrane-cleaving proteases (I-CliPs) are unusual
proteases that cleave their substrates within the membrane.
Several of these enzymes have been identified in the past
two decades and studied intensively. They belong to
different protease classes and include the GxGD-type aspar-
tate proteases presenilin (PS), signal peptide peptidase
(SPP) and its homologous SPP-like proteases, the S2P met-
alloproteases, and the rhomboid serine proteases (1). Very
recently, Rce1 was identified as a novel glutamate-type
I-CliP (2). PS is the catalytic subunit of g-secretase, a pro-
tease complex that contains nicastrin (NCT), APH-1, and
PEN-2 as additional subunits in a 1:1:1:1 stoichiometry
(3,4). Due to its close association with Alzheimer’s disease,
g-secretase is one of the best-studied I-CLiPs (5). The
enzyme generates ~4 kDa amyloid b-peptide (Ab) species
of different lengths from a C-terminal fragment of the
b-amyloid precursor protein (APP), termed APP CTFb or
C99. These include the major 40-amino-acid Ab species
Ab40 and a slightly longer species, Ab42, which is believed
to trigger Alzheimer’s disease (5). Mutations in PS and APP
are associated with genetically inherited forms of the dis-
ease (6).
Cleavage of integral membrane proteins within the hydro-
phobic environment of the lipid bilayer has been considered
an obscure process for a long time. Recently, purification
and crystallization of a handful of these proteases showed
that their active sites are deeply immersed in the membraneSubmitted October 23, 2014, and accepted for publication December 29,
2014.
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membrane proteolysis to occur (1). However, the detailed
mechanism of substrate recruitment and cleavage, as well
as the underlying kinetics, remains largely unclear.
Cell-free assays in which detergent-solubilized I-CliPs,
purified to various grades, are capable of cleaving a substrate
in either micelles or lipid bilayers, have allowed
investigators to study the enzymatic properties of I-CLiPs
in more detail and to determine some of the key enzyme
kinetic constants (7–12). Thus, data for the Michaelis con-
stant KM have become available for various I-CLiPs. How-
ever, an equally important parameter, the turnover number
kcat, has not been determined so far. Only recently, surpris-
ingly low values of kcat were reported for rhomboids (e.g.,
only 0.0063 s1 for E. coliGlpG, a well-characterized rhom-
boid (12)). Additionally, the reported kcat/KM value of GlpG
showed that rhomboid substrate cleavage is highly ineffi-
cient compared with that of other well-studied proteases.
These properties were recently confirmed (13). In this study,
we determined kcat and kcat/KM of g-secretase for its APP
CTFb substrate, the precursor of Ab, both in vitro and in
cultured cells. Remarkably, we found that, like rhomboids,
g-secretase is a very slow and inefficient enzyme.MATERIALS AND METHODS
Antibodies
The monoclonal antibody to the NCTectodomain (ectoNCT; Clone 35) was
obtained from BD Signal Transduction Laboratories, and the monoclonal
anti-His5 antibody was obtained from Qiagen. The following antibodies
were used for analysis of Ab: 2D8 to Ab1-16 (14), 4G8 to Ab17-24
(Covance), and C-terminal specific Ab antibodies to Ab38, Ab40, and
Ab42 (15).http://dx.doi.org/10.1016/j.bpj.2014.12.045
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Human embryonic kidney 293 (HEK293) cells stably expressing Swedish
mutant APP (APPsw; HEK293/sw) were described previously (16).
HEK293-EBNA cells stably transfected with a fusion protein of ectoNCT
with the IgG1 hinge-CH3 heavy chain (NCT-IgG) were described
before (17).Purification and reconstitution of g-secretase into
lipid vesicles
Detergent-solubilized endogenous human g-secretase was isolated from
HEK293 cells by a multistep purification procedure as described previously
(18). To reconstitute g-secretase into a lipid bilayer, first small unilamellar
vesicles (SUVs) of palmitoyl-oleoyl-phosphatidylcholine (POPC) were
prepared by sonication. Subsequently, the enzyme was reconstituted into
the SUVs by detergent dilution, followed by a 4 h incubation at 4C (19).
As reported previously (19), electron microscopy and dynamic light scat-
tering analyses demonstrated that our SUVs and the proteoliposomes
derived from them, respectively, are unilamellar and have a size of ~30 nm.Purification of ectoNCT
HEK293-EBNA cells stably expressing NCT-IgG were used to purify
ectoNCT as described previously (17) with minor modifications. In brief,
cells were cultured in Opti-MEM medium, and secreted NCT-IgG was
captured by immunoprecipitation using Protein A-sepharose. Bound
NCT-IgG was extensively washed with STEN-NaCl (50 mM Tris,
500 mM NaCl, 2 mM EDTA, 0.2% NP-40, pH 7.6), STEN (50 mM Tris,
150 mM NaCl; 2 mM EDTA; 0.2% NP-40, pH 7.6), and finally with Factor
Xa buffer (20 mM Tris, 100 mM NaCl, 2 mM CaCl2, pH 8.0), in which all
subsequent steps were carried out. NCT-IgG was cleaved with Factor Xa
(New England Biolabs) to release ectoNCT, which was further purified
using WGA-agarose beads (Calbiochem). After overnight binding and sub-
sequent washing, ectoNCTwas eluted from the WGA-agarose beads using
250 mM N-acetylglucosamine. The purity of the ectoNCTwas analyzed by
combined western blot/Ponceau S staining analysis and its concentration
was determined with the Bradford method.Kinetic model of substrate processing by
g-secretase
g-Secretase cleaves its APP CTFb substrate in a complicated stepwise
manner starting with an endoproteolytic cleavage at the ε-site, releasing
the amyloid precursor protein intracellular domain (AICD), followed by
carboxy-terminal trimming, liberating Ab species of different lengths
(20). Since the initially generated longer and intermediate Ab forms
Ab49(48) and Ab46(45) are not measurable in our analysis, our kinetic
model applies to the overall substrate processing by g-secretase to the final
Ab end products, i.e., the generation of the major Ab species (mainly Ab42,
Ab40, and Ab38). This simplified kinetic analysis is based on the following
reaction:
APP CTFbþ E#ES!kcat Ab (1)
where APP CTFb is the substrate, E is the free g-secretase enzyme, ES is
the enzyme-substrate complex, and Ab is the sum of the Ab end products.
Applying Michaelis-Menten kinetics to this reaction, we obtain
V ¼ Vmax  SðSþ KMÞ ¼ kcat  Et 
S
ðSþ KMÞ
(2)Biophysical Journal 108(5) 1229–1237where V is the steady-state rate of the reaction, KM is the Michaelis-Menten
constant, S is the substrate concentration, Et is the total enzyme con-
centration, and kcat is the turnover number of overall APP CTFb substrate
processing by g-secretase.Determination of KM and Vmax of g-secretase
in vitro
Purified recombinant APP C100-His6 substrate was prepared as previously
described (3) and added to aliquots of proteoliposomes at room temperature
(RT) followed by immediate incubation at 37C.The pHof the assaymixture
was 6.4 (19), i.e., in the range of the reported optimal pH of g-secretase
(pH 6.3–6.5) (21,22). The reaction was stopped at different time points by
addition of an excess amount of PBS containing 0.5% Triton X-100. The
respective amounts of Ab (Ab38 þ Ab40 þ Ab42) generated in the assay
were then measured by Ab sandwich immunoassay as previously described
(14). From these data, the total Ab concentration in the incubation volume of
the proteoliposomes was calculated. One purified enzyme preparation was
used for three independent experiments with four different substrate con-
centrations (0.1, 0.2, 0.4, and 0.8 mM), and Ab was measured after 0, 4, 8,
and 16 h of incubation. Another enzyme preparation was used for two larger
experiments with five different substrate concentrations (0.2, 0.4, 0.8, 1.2,
and 1.6 mM). In these experiments, Ab was measured after 0, 1, 2, 3, 4, 8,
16, and 32 h of incubation. To compare the results obtained with the proteo-
liposomes of the two different enzyme preparations, the concentration of Ab
generated at each time point was normalizedwith respect to the total concen-
tration of g-secretase, which was determined by NCT quantitation as
described below. Subsequently, we evaluated whether the changes in the
concentration of Ab followed first-order kinetics with time t, i.e.,
d½AbðtÞ=dt ¼ k  ½AbðNÞ-AbðtÞ (3)
where k is the rate constant, Ab(N) is the final Ab concentration, and Ab(t)
the concentration of Ab at incubation time t. Assuming that Ab(0) ¼ 0, the
solution of this equation becomes
AbðtÞ ¼ AbðNÞ  1 e kt (4)
Using GraphPad PRISM 5.0 software, the parameters k and Ab(N) of the
one phase association function (Eq. 4) were fitted to all data points (i.e.,
Ab(t) at t ¼ 0, 1, 2, 3, 4, 8, 16, and 32 h). Subsequently, the initial rates
of Ab production (V0) were determined from the fitted linear slopes of
Ab formation from the data points at t ¼ 0, 1, 2, 3, 4, and 8 h. Values of
Vmax and apparent KM were then calculated by plotting V0 against S and
fitting the data to the Michaelis-Menten equation (Eq. 2) by nonlinear
regression, using Vmax and KM as independent variables.Quantification of total and active g-secretase
The total amount of g-secretase in the proteoliposomes (Et) was determined
by immunoblotting using the monoclonal anti-NCT antibody and quantifi-
cation of NCT with known amounts of purified ectoNCT (17) as protein
standard by measuring the respective enhanced chemiluminescence
(ECL) signal intensities using the FluorChem 8900 detection system (Alpha
Innotech). The concentration of active enzyme (Ea) in the proteoliposomes
was determined by active-site titration as outlined previously (23). In brief,
after a 1 h preincubation of g-secretase proteoliposomes at RT in the pres-
ence of increasing concentrations of the transition-state analog inhibitor
L-685,458 (24), 0.5 mM C100-His6 was added and substrate cleavage was
allowed to proceed overnight at 37C. The Ab and AICD immunoblot sig-
nals obtained with 2D8 and anti-His5 antibodies, respectively, were quanti-
fied as above using the FluorChem 8900 detection system. The amounts of
Ab and AICD produced in the absence of inhibitor were set to 100%. Ea was
then extrapolated from the linear decrease in enzyme activity (23).
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Two experimental groups (groups A and B) consisting of six independent
cultures of HEK293/sw cells were incubated at 37C to allow secretion
of Ab. For each group, cultures 1–3 were analyzed after 4 h and cultures
4–6 were analyzed after 8 h. After the respective incubation times, the
rate of total Ab production (V) was derived from the amount of total
secreted Ab, which was quantified via an Ab sandwich immunoassay as
previously described (15). Levels of cellular g-secretase and APP CTFb
substrate were determined from cell lysates (prepared with STEN-lysis
buffer (50 mM Tris, pH 7.6, 150 mM NaCl, 2 mM EDTA, 1% Nonidet
P-40, and protease inhibitors (Sigma)) additionally containing 1% SDS)
by immunoblotting using the monoclonal anti-NCT antibody or antibody
2D8, respectively, and quantitation of the immunoblot signals using known
amounts of ectoNCT or C100-His6 as protein standards. kcat was calculated
from the Michaelis-Menten equation.
kcat ¼ V  ðSþ KMÞ
S
 1
Et
(5)
Here KM is the real KM, i.e., the KM with respect to the volume of the POPC
bilayer of the proteoliposomes. The real KM was derived from the apparent
KM ðK 0MÞ determined in vitro (see Eq. 13 below). To calculate S per volume
of the lipid phase of the cells, an estimation of the amount of plasma mem-
brane (PM) and endosomal lipids relative to the experimentally determined
total cellular protein amount of the cell lysates was required. From the
amount of these lipids, the volume of the lipid phase was calculated. Sub-
sequently, S was calculated from the amount of cellular APP CTFb divided
by the volume of the lipids. From the experimental data, Vwas calculated as
pmol/h and Et was calculated as pmol. Consequently, the dimension of kcat
calculated from Eq. 5 is h1. Alternatively, kcat was recalculated from Eq. 5
using the in vitro real KM relative to the surface area of the proteoliposomes
(Eq. 14 below), and recalculating S in the cells relative to the surface area of
PM and endosomal membranes.Estimation of the volume and surface area of PM
and endosomal lipids in HEK293 cells
First, we estimated the total amount of phospholipids in the PM and endo-
somal compartments. The experimentally determined phospholipid/protein
ratio for HEK293 cells is ~125 nmol phospholipids/mg protein (25). In
baby hamster kidney (BHK) cells, which presumably have a similar distri-
bution of lipids among the different cell compartments compared with
HEK293 cells, it was previously found that 17% of the cellular phospho-
lipids are in the PM (26). To estimate the amount of lipids in the endosomal
fraction, we used data from a previous electron microscopy study of BHK
cells (27), which reported that the membrane surface of endosomes is 430
mm2/cell and the total membrane area is 15,860 mm2/cell. Thus, the percent-
age of lipids of the endosomal fraction relative to the total membrane lipids
is 430/15,860 ¼ 2.7%. Combining these data, we concluded that for BHK
cells, the PM and endosomal fraction contain ~20% of the total cellular
phospholipids. Thus, we calculated the amount of phospholipids of
HEK293 cells as
PM and endosomal phospholipids
¼ 0:20  125 nmol=mg protein
¼ 25 nmol=mg protein (6)
To estimate the volume of this phospholipid fraction, we assumed that the
average volume of the cellular phospholipid species (i.e., choline, ethanol-
amine, anionic phospholipids, and sphingomyelins) is similar to the volume
of POPC, i.e., 1100 A˚3/POPC molecule, which is justified (28). Thus, the
volume of the phospholipid fraction isVolume phospholipids ¼ NAV  1100 A3
¼ 0:66 nl=nmol phospholipids
(7)
Since one PCmolecule at the lipid-water interface of a phospholipid bilayer
occupies 71.7 A˚2 (28), the total surface area of a bilayer of PC becomes
Surface area phospholipids ¼ NAV  71:7 A2
.
mol lipid
¼ 4:32  108mm2nmol phospholipids
(8)
To calculate the volume and surface area of additional membrane lipids,
we took their distribution into account. For the PM of BHK cells, a com-
position of 63% w/w phospholipids, 30% w/w cholesterol, and 7% other
lipids (such as glycolipids) was previously reported (26). Similar lipid dis-
tributions were found for the PM of other mammalian cells (29–31).
Neglecting the 7% other lipids, we assumed that the PM and the endosomal
membranes for HEK293 cells are composed of phospholipids and choles-
terol only, at a 2:1 (w/w) ratio. Since on average the molecular weight
(MW) of phospholipids is about twice that of cholesterol, we calculated
the volume of all lipids from the sum of all phospholipids and cholesterol,
taking a 1:1 molar ratio. The volume of one cholesterol molecule is
623 A˚3 (28).
Volume cholesterol ¼ NAV  623 A3
¼ 0:38 nl=nmol cholesterol (9)
Since the surface area of one cholesterol molecule at the lipid-water inter-
face of a bilayer of a PC/cholesterol mixture is 37 A˚2 (28,32), the surface
area of the cholesterol fraction of the membrane is
Surface area cholesterol ¼ NAV  37 A2
.
mol lipid
¼ 2:22  108mm2nmol cholesterol
(10)
Combining Eq. 6 with Eqs. 7 and 9, we obtain
Volume of all PM and endosomal lipids
¼ 25  ð0:66þ 0:38Þ ¼ 26:0 nl=mg cellular protein
(11)
Combining Eq. 6 with Eqs. 8 and 10, we obtain
Surface area of all PM and endosomal lipids
¼ 25  ð4:32þ 2:22Þ  108
¼ 163:5  108mm2mg cellular protein (12)
RESULTS
Determination of kcat and apparent KM in vitro
To determine kcat as well as kcat/KM of g-secretase, we used
our previously established cell-free in vitro assay in whichBiophysical Journal 108(5) 1229–1237
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constituted into preformed SUVs composed of POPC (19).
Purified C100-His6 g-secretase substrate, a recombinant
APP CTFb variant (3), was added at different concentra-
tions to the proteoliposomes. For each substrate concentra-
tion (S), we measured the corresponding Ab production at
different time points of incubation at 37C using an Ab
immunoassay (15) (Fig. 1 A). There was no apparent ma-
jor delay in the production of Ab upon addition of sub-
strate to the proteoliposomes (Fig. 1 A), suggesting that
the added substrate is incorporated instantaneously into
the proteoliposomes. To correct for variations in enzyme
activity of the proteoliposome preparations used, we
normalized the Ab production of each individual experi-
ment with respect to the total enzyme concentration Et.
To determine the Et of the proteoliposomes, we used puri-
fied recombinant ectoNCT as a standard (see Fig. 2, A–D).
The concentrations of Ab during time t (Fig. 1 A) were
fitted to single exponential association kinetics (Eq. 4).
From the fitted endpoints (Ab(N)), we found that the final
Ab concentration was on average ~35% of the initial sub-
strate concentration, i.e., only 35% of added substrate
could be processed by g-secretase (see Discussion below).
For each substrate concentration, the initial rate (V0) was
determined from the linear increase in the concentration
of Ab during the first 8 h of incubation (Fig. 1 B). The
good fits indicated that the steady-state condition
(S>>E) was fulfilled at all of the substrate concentrations
used. Finally, V0 was plotted against S (Fig. 1 C). Vmax and
apparent KM ðK0MÞ were derived by fitting the data to the
Michaelis-Menten equation (Eq. 2). The average value of
Vmax was 0.476 5 0.047 nM Ab h
1 nM NCT1 and
K
0
M was 0.285 5 0.091 mM. Although our K
0
M value
was comparable to those previously reported by othersA B
FIGURE 1 In vitro kinetics of g-secretase. (A) Time course of in vitro Ab gene
0.2, 0.4, 0.8, 1.2, and 1.6 mM of C100-His6 APP substrate, respectively, at 37
C
respective concentration of total Ab was measured. The data points represent t
Methods). Note that for some data points the error bars are too small to be displ
netics. (B) Data from A for the first 8 h of incubation. For each substrate concent
increase of Ab during time. (C) Michaelis-Menten plot. For each individual subs
taken. The line represents the fit of the data points to the Michaelis-Menten eq
NCT1) and K
0
M (0.2855 0.091 mM) were obtained.
Biophysical Journal 108(5) 1229–1237(7–11), our Vmax value cannot be strictly compared with
previously published values, since the enzyme concentra-
tions in the previous studies were not determined and
may have varied (8–11).
Our Vmax, expressed in a dimension normalized to Et, is in
fact the turnover number, i.e., kcat ¼ 0.476 h1. However,
since only a small fraction of reconstituted g-secretase is
in an active conformation (18), this evaluation of kcat is
probably an underestimation. By determining the active
enzyme concentration (Ea) with active-site titration experi-
ments, we found that in four different proteoliposome prep-
arations, including those used for Fig. 1 A, Ea was on
average only 11% of Et (Fig. 2, E and F). Taking this into
account, we conclude that kcat is 9.1 times higher, i.e., kcat¼
4.33 5 0.43 h1.Determination of real KM and catalytic efficiency
kcat/KM
To next calculate kcat/KM of g-secretase in proteoliposomes,
one should bear in mind that in our assay the substrate and
the enzyme are both present in the membrane. Thus, the real
concentration of the substrate depends on the amount of
lipids in the assay and not on the total aqueous volume of
the incubation assay (33). In our in vitro assay, the lipid con-
centration was 0.7 mM. This means that the real KM equals
0.285 mM/0.7 mM ¼ 0.041 mol% relative to phospholipid,
which is ~3 times lower than the KM value of 0.14 mol%
reported for rhomboid GlpG (12).
Alternatively, to calculate the real KM relative to the vol-
ume of the membrane, we assumed that the volume of one
POPC molecule in a lipid bilayer is 1100 A˚3 (28). Thus,
the real KM, relative to the volume of the phospholipids
(Eq. 7) isC
ration by g-secretase. g-Secretase proteoliposomes were incubated with 0.1,
. For each indicated incubation time (t ¼ 0, 1, 2, 3, 4, 8, 16, and 32 h), the
he mean 5 SE of two to five independent experiments (see Materials and
ayed. The lines represent fitted curves to single exponential association ki-
ration, V0 was obtained from the slope at t ¼ 0 by fitting the data to a linear
trate concentration (S), the fitted mean5 SE of V0 from the data in (B) was
uation. From this fit, the values for Vmax (0.476 5 0.047 nM Ab h
1 nM
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FIGURE 2 Quantification of g-secretase in the
in vitro assay. (A) SDS-PAGE analysis of the re-
combinant ectoNCT. Ponceau S staining showed
that both ectoNCT preparations yielded purified
protein that migrated at the expected MW. A higher
degree of purity was obtained for the WGA-
purified ectoNCT, qualifying this protein prepara-
tion as standard for the g-secretase determination.
(B) Immunoblot analysis of g-secretase proteolipo-
somes in comparison with the ectoNCT protein
standard. Small aliquots of one of the proteolipo-
some preparations used for the in vitro assays
shown in Fig. 1 A were comigrated with known
amounts of purified ectoNCT protein standard
and detected with an anti-NCT monoclonal anti-
body. (C and D) Determination of total g-secretase
(Et). (C) The ECL signal intensities of the immu-
noblot shown in (B) were plotted to obtain an
ectoNCT standard calibration curve. (D) From the
same immunoblot, the ECL signal intensities of
aliquots of the proteoliposomes were compared
with the calibration curve, allowing for an estima-
tion of the concentration of NCT, i.e., the total
g-secretase present in the proteoliposomes. Et
was 34 nM. (E) Active-site titration of g-secretase.
There was a close correlation between the decrease
in Ab and AICD production with increasing
L-685,458 concentrations. Data points represent
the mean 5 SE of three measurements. Ea was
3.42 nM or 3.21 nM based on the extrapolation
of Ab and AICD data, respectively. (F) Determina-
tion of the active g-secretase enzyme pool. Et,
determined from the amount of NCT (D) was
compared with Ea, determined from the active
site inhibitor titration (E). The fraction of active
g-secretase in proteoliposomes (Ea/Et) was 10.1%
and 9.5% based on the Ab and AICD data (E),
respectively. In a total of four independent enzyme
purifications, we found that only 11% (mean 5
SE¼ 10.85 1.2) of g-secretase present in the pro-
teoliposomes was in an active conformation.
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0
Mðmol substrate=1Þ
0:7 , 103ðmol lipid=1Þ 
1
0:66 ðliter lipid=mol lipidÞ
¼ K0M  2165

mol substrate
liter lipid

(13)Applying Eq. 13, the real KM becomes 0.285 mM  2165 ¼
0.617 mM. Correcting also for the observation that on
average only 35% of added substrate was available for
cleavage (Fig. 1 A), the real KM becomes 0.35 
0.617 mM ¼ 0.216 mM. Thus, we calculate the catalytic
efficiency of g-secretase as kcat/KM ¼ 0.0012 s1/
0.216 mM ¼ 5.6 s1M1.
Since association of the substrate to g-secretase is a two-
dimensional diffusion process, it is also meaningful to
express KM as mol/area. Because the surface area of a
bilayer of POPC is NAV  71.7 A˚2/mol lipid (Eq. 8), the
real KM is calculated as follows:KM¼ K
0
Mðmol substate=1Þ
0:7 , 103ðmol lipid=1Þ 
1
NAV 71:7

A
2
mol lipid

¼ K
0
M
302

mol substrate
m2

(14)
Applying Eq. 14, the real KM becomes 0.285 106 /302¼
0.94 nmol/m2. Again with the correction that 35% of
substrate was available for cleavage (Fig. 1 A), the real
KM becomes 0.35  0.94 ¼ 0.33 nmol/m2.Determination of kcat and KM in HEK293 cells
Since in vitro g-secretase appeared to be such a slow
enzyme (kcat ¼ 4.33 h1), we sought to also estimate the
kcat value for g-secretase in living cells. To this end, we
allowed two independent groups of cultured HEK293/sw
cells (groups A and B) to secrete Ab for either 4 h or 8 hBiophysical Journal 108(5) 1229–1237
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FIGURE 3 Determination of cellular g-secretase
and APP CTFb levels, and Ab production rates.
(A and B) Immunoblot analysis of cellular g-secre-
tase and APP CTFb levels. Two groups of six inde-
pendent cultures (A1–A6 and B1–B6, respectively)
of HEK293/sw cells were analyzed. Cultures 1–3
of each group were analyzed after 4 h and cultures
4–6 after 8 h. Equal aliquots of the corresponding
cell lysates were immunoblotted with the mono-
clonal anti-NCT antibody and with antibody 2D8
to APP CTFb, respectively. The signals were
compared with known amounts of purified ec-
toNCT and C100-His6 loaded on the same gel
(Std.). Immunoblot signals of the ectoNCT (see
Fig. 2 C) and C100-His6 protein standards (B)
were in the linear range. Note that the cell lysates
of the cultures of group A were generated in half
the volume compared with those of group B to
adjust for the ~2-fold higher cell number of the cul-
tures of group B. (C) Quantification of A. The ECL
signal intensities of the immunoblots shown in A
were used to determine the protein amount of g-
secretase and APP CTFb. (D) Ab production rate.
The average rate of total Ab production for groups
A and B was calculated from the amount of total
secreted Ab in media conditioned for 4 h and 8 h,
measured by an Ab sandwich immunoassay detect-
ing all secreted Ab species. In (C) and (D), data are
represented as mean5 SE (n ¼ 3).
1234 Kamp et al.(Fig. 3, A–D). We then measured the steady-state rate of Ab
production (V), the total protein, the steady-state amount
of APP CTFb substrate, the amount of total g-secretase,
and calculated kcat as described in Materials and Methods.
In the first three cell lines of group A (Fig. 3, A–D), after
4 h, V was 0.4335 0.014 pmol/h. The APP CTFb substrate
amount in the cell lysates was 0.3115 0.021 pmol and the
amount of g-secretase complexes was 0.9365 0.056 pmol.
We assumed that the real KM value determined in vitro
would be the same in cells (KM ¼ 0.216 mM). Thus, from
the measured amount of APP CTFb in the cell lysates, we
needed to calculate the substrate concentration in the cells
relative to the lipid volume. Since it was not possible to
experimentally determine the amount of lipids of the
cellular organelles in which g-secretase was embedded,
we made an estimation taking into account that Ab genera-
tion by g-secretase from APPsw occurs both at the PM and
in endosomes (34,35). To calculate the lipid content of these
cellular compartments, we used data from the literature (see
Materials and Methods). The total protein of the cell lysates
was 596 5 23 mg, so that the total volume of the PM
and endosomal fraction, as calculated from Eq. 11, was
26.0  0.596 ¼15.5 nl. Thus, the steady-state APP CTFb
concentration relative to the volume of PM and endosomal
lipids was 0.311 pmol/15.5 nl ¼ 0.0201 mM. Finally,
applying Eq. 5, we calculated kcat ¼ 5.43 h1. We also
repeated the calculation for the three cell lines of group A
with 8 h Ab secretion and the cell lines of group B.
The average of these four determinations was 6.00 5Biophysical Journal 108(5) 1229–12370.34 h1, which is similar to the in vitro kcat. Alternatively,
when we recalculated the substrate concentration with
respect to the surface area of the PM and endosomal lipids
(Eq. 12), and used the real KM of g-secretase relative to
the surface area of POPC (KM ¼ 0.33 nmol/m2), the kcat
calculated from the cellular experiments was 5.8 h1. This
is nearly indistinguishable from the cellular kcat (6.0 h
1)
calculated based on the volume of the lipids.DISCUSSION
To better understand the kinetics of g-secretase, we set out
to determine the turnover number kcat, which had remained
elusive in previous enzyme kinetic studies of g-secretase
(7–11). Similarly to the kcat values reported for rhomboids
(12), the kcat of g-secretase was very low in the cell-free
assay (4.33 h1). Although our initially derived apparent
KM ðK0MÞ was similar to previous studies (7–11), for our
kinetic analysis of g-secretase, we took into consideration
the fact that the substrate and enzyme are both embedded
in the membrane. Therefore, we calculated a real KM in a
dimension with respect to the lipid phase (33). Furthermore,
the K
0
M of g-secretase derived from the Michaelis-Menten
plot (Fig. 1 C) also had to be corrected for the fact that
not all added substrate was cleaved in the in vitro assay.
This was not unexpected, as a random membrane orienta-
tion of both substrate and enzyme theoretically would lead
to a 50% mismatch, such that maximally 50% of the sub-
strate could be cleaved. Since we found that only 35% of
g-Secretase Is a Slow Enzyme 1235added substrate could be processed by g-secretase, indeed a
partial mismatch between the orientation of the incorporated
substrate and the orientation of the reconstituted enzyme in
the membrane might have occurred. Additionally, a fraction
of the added substrate may not have assumed a cleavable
transmembrane conformation. Taking all of these consider-
ations into account, we found that the real KM was
0.216 mM, which is comparable to the real KM that we
calculated for rhomboids (Table 1) from the previously re-
ported data (12) by taking the volume of the lipid bilayer
of the proteoliposomes into account.
Using the real KM in vitro, we were able to experimentally
determine the kcat in cells. We found a remarkably good
match between the kcat determined in vitro (kcat ¼ 4.33
h1) and that approximated in cells (kcat ¼ 6.0 h1), despite
several assumptions that we made to calculate kcat from the
measured cellular rate of Ab production and the steady-
state substrate concentration. We first assumed that the
Michaelis-Menten equation (Eq. 5) applied in our experi-
ment with living cells. The validation of the Michaelis-
Menten equation assumes steady-state kinetics, i.e., d[ES]/
dt¼ 0, which is fulfilled in vitro when Et is at least five times
less than S (13,14). Although we found in our cells that the
enzyme concentration is larger than the substrate concentra-
tion, d[ES]/dt ¼ 0 is nevertheless fulfilled because the APP
CTFb substrate concentration is a steady-state concentra-
tion. Second, we assumed that the real KM of APP CTFb
in the cells is the same as the real KM of C100-His6
in vitro. We calculated the real KM from the apparent KM
obtained from the in vitro experiment, taking the POPC
lipids into account. Although POPC is the most common
phospholipid in biological membranes, it is possible that
other lipids present in cellular membranes alter the KM.
Third, for cells, we determined their steady-state APP
CTFb concentration per volume of the PM and endosomalTABLE 1 Comparison of real KM, kcat, and kcat/KM of
g-secretase and other selected proteases
Protease Substrate KM (mM) kcat (s
1)
kcat/KM
(s1M1)
g-Secretasea APP CTFb
(C100-His6)
0.216 0.00120 5.6
g-Secretaseb APP CTFb (C99) 0.216 0.00167 7.7
Rhomboid GlpGc FITC-TatA 2.1 0.0063 3
Rhomboid GlpGd FITC-TatA 0.135 0.0407 301
Rhomboid GlpGe TatA-Flag 2.9 0.0069 2.4
Reninf Angiotensinogen 0.0011 2.4 2.2 106
Chymosing k-Casein 0.032 93.3 2.9 106
aDetermined for the proteoliposome-based assay.
bDetermined for cultured HEK293 cells, assuming that KM is the same as
in vitro.
cCalculated for the proteoliposome-based assay (KM ¼ 0.14 mol% (12)).
dCalculated for the micelle-based assay (12).
eCalculated for cultured E. coli cells (KM ¼ 0.19 mol% (12)).
fTaken from Nguyen et al. (44).
gTaken from Vreeman et al. (45).lipids. Since substrate binding to g-secretase is a two-
dimensional process, we also calculated the cellular kcat us-
ing the in vitro real KM based on the surface area of the
membrane. However, there was almost no difference be-
tween the kcat calculated based on the surface area of the
cellular lipids (kcat 5.8 h
1) and the kcat (6.0 h
1) calculated
using the volume of these lipids. We further assumed that Et
can be determined by the total amount of NCT in the cells.
This is justified because there is evidence that g-secretase
complexes adopt an active conformation once they have
assembled in the ER (36,37). However, since the bulk of
g-secretase resides in the early compartments of the secre-
tory pathway where no APP CTFb substrate is present
(34,38), our determination of Et might be an overestimation
and our calculated cellular kcat an underestimation. Finally,
we did not take into account that g-secretase and APP CTFb
could segregate into raft domains in the membrane (39) and
thus locally the estimated substrate concentration would be
higher than that calculated based on the total amount of
lipids in the PM and endosomes. In this case, the local sub-
strate concentration would be higher and our calculated
cellular kcat would be an overestimation. However, despite
the above assumptions, we do not expect that the actual
cellular kcat is several orders of magnitudes larger.
As summarized in Table 1, g-secretase is a very slow pro-
tease with kinetics comparable to that of rhomboids such as
GlpG (12). In contrast, caspase-3, a cysteine protease,
cleaves natural substrates with ~500- to 1000-fold higher
kcat values and catalytic efficiencies kcat/KM of at least 10
4
M1 s1 (40). Likewise, the soluble aspartate protease renin
cleaves its natural substrate angiotensinogen ~103 times
faster than g-secretase, whereas chymosin, another aspar-
tate protease, is ~105 times faster (Table 1). To our knowl-
edge, only C5 convertase, a soluble serine protease of the
complement system, has an exceptionally low kcat for its
natural substrate (41). g-Secretase thus appears to be one
of the slowest and most inefficient proteases in nature.
Perhaps the lipid environment of g-secretase slows neces-
sary conformational changes of the enzyme-substrate com-
plex (42). Furthermore, since cleavage by g-secretase is a
multistep process, it is also possible that potential dissocia-
tion and reassociation of intermediary Ab forms slow down
the overall process (20,43).
An intriguing feature of g-secretase is that it can cleave
more than 90 different substrates (46), which do not share
obvious common features in their primary structure (47).
Apart from the requirement that most of the ectodomain
of its type I membrane protein substrates must be shed
(5), detailed mechanistic insight into how g-secretase dis-
criminates between substrates, as well as the role of KM
and kcat in this process, is still lacking. With regard to rhom-
boids, Dickey et al. (12) recently found that all substrates
bind very weakly to the enzyme, and that substrate discrim-
ination is governed by differences in kcat for different sub-
strates and not by different binding affinities, i.e., not byBiophysical Journal 108(5) 1229–1237
TABLE 2 Competition by kcat alone between two substrates of
chymotrypsin
Protease Substrate KM (mM) kcat (s
1) kcat/KM (s
1M1)
Chymotrypsina AcTyr-AlaNH2 17 7.5 440
Chymotrypsina AcPhe-GlyNH2 15 0.14 10
aTaken from Fersht (48).
1236 Kamp et al.the KM. They argued that this mechanism is a unique feature
of rhomboids. However, according to considerations by
Fersht (48) and others, competition between the substrates
of any enzyme is not governed by KM alone but by kcat/KM.
Thus, the ratio of the rates of product formation of two
competing substrates (A and B) is given by
VA
VB
¼ ðkcat=KMÞA  Aðkcat=KMÞB  B
(15)
Indeed, substrate competition by kcat alone will occur when
the K values are similar. This is illustrated in a specificM
example in Table 2 for the soluble serine protease chymo-
trypsin (48). For two selected peptide substrates of this pro-
tease, KM was similar but kcat varied by a factor of 54,
resulting in different kcat/KM ratios for the substrates.
Various other examples of this principle have been reported
(e.g., for the aspartate protease pepsin (49)). Thus, variation
of kcat can also be a property of soluble proteases to discrim-
inate between substrates and is not a unique property of
rhomboids (12). Moreover, according to the classic transi-
tion-state theory of catalysis (48), kcat is linked to the activa-
tion energy DG# for an enzyme-substrate complex ES to
reach a conformation ES# in which the protease is able to
cleave the substrate’s scissile bond (kcat ¼ kf  e(DG#/RT),
where kf is the forward rate constant). Due to intrinsic struc-
tural and motional differences in their respective transmem-
brane domains (42), the required DG#s of different
substrates to achieve a cleavable conformation might sub-
stantially vary. For some proteases, this may also involve
transitory substrate binding to an exosite, i.e., a binding
site distinct from the active site, which g-secretase and
rhomboids apparently have (1,8,12), although this is princi-
pally not necessary for substrate discrimination.CONCLUSIONS
Our results show that g-secretase, like rhomboids, is a very
slow enzyme, indicating that I-CLiPs may not have evolved
for high-rate protein degradation. In future studies, it will be
interesting to determine whether other I-CLiPs have simi-
larly low turnover numbers or rhomboids and g-secretase
are exceptional in this regard.Author Contributions
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